 Tumor Burden
"Tumor Burden" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The total amount (cell number, weight, size or volume) of tumor cells or tissue in the body.
| Descriptor ID |
D047368
|
| MeSH Number(s) |
E05.041.124.892
|
| Concept/Terms |
Tumor Burden- Tumor Burden
- Burden, Tumor
- Tumor Load
- Load, Tumor
- Loads, Tumor
- Tumor Loads
Tumor Weight- Tumor Weight
- Tumor Weights
- Weight, Tumor
- Weights, Tumor
|
Below are MeSH descriptors whose meaning is more general than "Tumor Burden".
Below are MeSH descriptors whose meaning is more specific than "Tumor Burden".
This graph shows the total number of publications written about "Tumor Burden" by people in this website by year, and whether "Tumor Burden" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 2 | 3 | | 2007 | 0 | 2 | 2 | | 2008 | 1 | 6 | 7 | | 2009 | 0 | 4 | 4 | | 2010 | 2 | 12 | 14 | | 2011 | 1 | 7 | 8 | | 2012 | 0 | 15 | 15 | | 2013 | 1 | 11 | 12 | | 2014 | 0 | 13 | 13 | | 2015 | 3 | 11 | 14 | | 2016 | 1 | 10 | 11 | | 2017 | 0 | 16 | 16 | | 2018 | 1 | 9 | 10 | | 2019 | 3 | 4 | 7 | | 2020 | 1 | 8 | 9 | | 2021 | 0 | 10 | 10 | | 2022 | 0 | 8 | 8 | | 2023 | 0 | 4 | 4 | | 2024 | 3 | 2 | 5 | | 2025 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Tumor Burden" by people in Profiles.
-
Kawashima J, Akabane M, Khalil M, Woldesenbet S, Endo Y, Sahara K, Cauchy F, Aucejo F, Marques HP, Lopes R, Rodriguea A, Hugh T, Shen F, Maithel SK, Groot Koerkamp B, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzenente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma. Br J Surg. 2025 Mar 28; 112(4).
-
Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F, Shen F, Maithel S, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Marques H, Groot Koerkamp B, Endo I, Pawlik TM. The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2025 Jun; 32(6):4341-4351.
-
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Impact of disparity between imaging and pathological tumor size on cancer-specific prognosis among patients with hepatocellular carcinoma. Eur J Surg Oncol. 2025 Jun; 51(6):109683.
-
Altaf A, Khalil M, Akabane M, Rashid Z, Kawashima J, Zindani S, Ruzzenente A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Aucejo F, Kitago M, Popescu I, Martel G, Gleisner A, Bauer TW, Hugh T, Bhimani N, Shen F, Endo I, Pawlik TM. Up-front resection for hepatocellular carcinoma: Assessing futility in the preoperative setting. Eur J Surg Oncol. 2025 May; 51(5):109594.
-
Smith JD, Darr OAF, Haring CT, Rosko AJ, Spector ME, Heft-Neal ME. Nerve dissection technique for excision of parotid tumors: Outcomes controlling for tumor size and location. Am J Otolaryngol. 2025 Jan-Feb; 46(1):104582.
-
Akabane M, Kawashima J, Woldesenbet S, Altaf A, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma. J Gastrointest Surg. 2025 Feb; 29(2):101903.
-
Brooks T, Gao D, Dorris K, Boone K, Mirsky DM, Staulcup S, Prince E, Moskalenko M, Ignowski E, Wandrey N, Fakhoury K, Hankinson TC, Milgrom SA. Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma? J Neurosurg Pediatr. 2024 Dec 01; 34(6):642-648.
-
Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Yang J, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Alexandrescu S, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Prognostic significance of postoperative complications for patients with hepatocellular carcinoma relative to alpha-feto protein and tumor burden score. HPB (Oxford). 2024 08; 26(8):998-1006.
-
Alderuccio JP, Reis IM, Hamadani M, Nachiappan M, Leslom S, Kahl BS, Ai WZ, Radford J, Solh M, Ardeshna KM, Hess BT, Lunning MA, Zinzani PL, Stathis A, Carlo-Stella C, Lossos IS, Caimi PF, Han S, Yang F, Kuker RA, Moskowitz CH. PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial. Clin Cancer Res. 2024 01 05; 30(1):139-149.
-
Hoebel KV, Bridge CP, Kim A, Gerstner ER, Ly IK, Deng F, DeSalvo MN, Dietrich J, Huang R, Huang SY, Pomerantz SR, Vagvala S, Rosen BR, Kalpathy-Cramer J. Not without Context-A Multiple Methods Study on Evaluation and Correction of Automated Brain Tumor Segmentations by Experts. Acad Radiol. 2024 04; 31(4):1572-1582.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|